Baisi Medical Diagnostic Technology (Beijing) Co., Ltd announced that it will receive CNY 20,000,000 in an equity round of funding on March 18, 2022. The transaction will include participation from new investor Beijing Juli Changxin Enterprise Management Consulting Partnership (Limited Partnership) for CNY 6,000,000 for 20% stake, Yan Changwei for CNY 7,500,000 for 25% stake and returning investor Acrobiosystems Co.,Ltd. for CNY 6,500,000, where its stake decrease from 100% to 55%. The transaction was approved by the board of directors Acrobiosystems Co.,Ltd. at its fourteenth meeting of the first board of directors and the seventh meeting of the first board of supervisors.

Post to the closing, the registered capital of the company will increase from CNY 10,000,000 to CNY 30,000,000.